查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1970926

门诊心电图（ECG）市场－全球产业规模、份额、趋势、机会、预测：按类型、应用、地区和竞争格局划分，2021-2031年

Ambulatory Electrocardiography ECG Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球携带式心电图 (ECG) 市场预计将从 2025 年的 5.6545 亿美元成长到 2031 年的 8.6732 亿美元，复合年增长率为 7.39%。

在这个领域，诸如心电图监测和携带式遥测系统等便携式设备被用于持续监测心臟的电活动，使患者能够继续日常生活。推动该市场发展的关键因素包括全球心血管疾病和心房颤动发生率的上升，以及人口老化对频繁心臟监测的需求。此外，医疗保健系统向远端患者监护的策略转变，旨在减少住院治疗，也进一步推动了对这些诊断设备的需求成长。

市场概览
预测期 2027-2031
市场规模：2025年 5.6545亿美元
市场规模：2031年 8.6732亿美元
复合年增长率：2026-2031年 7.39%
成长最快的细分市场 可携式的
最大的市场 北美洲

然而，市场成长面临许多重大障碍，包括复杂的报销通讯协定和资料管理难题，阻碍了小规模医疗机构的采用。根据欧洲心臟学会2024年的数据，成员国每年将有超过300万人死于心血管疾病。虽然这项数据凸显了普及诊断工具的迫切性，但资金限制和监管复杂性仍然是市场广泛采用的障碍。

市场驱动因素

心血管疾病和心律不整发生率的上升是全球携带式心电图（ECG）市场的主要驱动力。随着心臟病在全球范围内的影响日益加剧，医疗系统越来越重视能够早期发现和治疗心房颤动及其他传导障碍的连续性、非侵入性监测方法。这项关键的临床需求源自于这些疾病死亡率的上升。根据世界卫生组织（WHO）2025年7月发布的心血管疾病（CVD）的说明书，预计2022年全球将有1,980万人死于心血管疾病，约占全球死亡总数的32%。因此，随着医疗服务提供者努力在标准医院环境之外进行及时诊断以改善患者预后，对心电图监测和行动遥测系统等携带式监测设备的需求激增。

推动市场成长的第二个关键因素是技术突破以及人工智慧 (AI) 在穿戴式装置中的应用。这些创新正迅速改变产业格局，从笨重的有线记录器转向配备 AI 演算法的隐藏式贴片感测器，用于即时检测心律不整和抑制噪音。例如，根据 2025 年 7 月出版的《心血管商业》杂誌报道，美国食品药物管理局(FDA)核准了Cardiosense 公司的 CardioTag，这是一款新型可穿戴感测器，能够同时记录心电图 (ECG) 和其他生理指标，以评估心臟功能。此类技术进步正带来显着的商业性成功和广泛的应用。根据 iRhythm Technologies 公司于 2025 年 2 月发布的“2024 年第四季度及全年财务业绩报告”，该公司年收入增长 20.1%，达到 5.918 亿美元，主要得益于其 Zio携带式监测服务的使用量增加。

市场挑战

复杂的报销系统和资料管理难题是携带式心电图市场扩张的主要障碍。医疗机构，尤其是小规模独立诊所，在取得长期监测服务费用所需的行政工作中经常遇到困难。复杂的编码结构和不一致的保险覆盖标准导致收入不确定性，使得医疗机构不愿投资先进的行动遥测系统。此外，持续监测产生的大量数据需要大规模的储存和处理能力，这给缺乏先进资讯技术基础设施的机构带来了额外的经济负担。

这些营运障碍有效地限制了向大型医院网路提供服务，阻碍了市场扩张。当诊所无法有效处理诊断数据或保证报销时，它们开立门诊监测处方的可能性就会降低，从而限制了市场规模。鑑于需要治疗的患者数量庞大，这瓶颈尤为严重。根据美国心臟协会预测，到2024年，约有48.6%的美国成年人将受到心血管疾病的影响。这一数字凸显了数据管理挑战的严峻性，因为心臟病的广泛流行需要可扩展的基础设施，而许多医疗机构目前由于监管和经济方面的限製而无法做到这一点。

市场趋势

消费级穿戴装置与临床级心电图 (ECG) 技术的整合正在改变患者照护路径，使广泛普及的装置也能实现医疗级心律不整检测。製造商们正不断获得监管部门的核准，推出多感测器设备，使患者能够在家中记录单导联心电图，从而减少对医疗机构诊断的依赖。这项进步将临床层级的精准度带入日常生活，有效弥合生活方式追踪与专业医疗监测之间的差距，支持对诸如心房颤动等疾病的早期治疗。根据 Femtech Insider 2025 年 11 月发表的题为「Withings BeamO 获得 FDA 批准」的报导，Withings 的 BeamO 获得了 FDA 批准。 BeamO 是一款多功能设备，整合了心电图和其他感测器，可在不到一分钟的时间内完成详细的健康核准。

同时，用于即时监测的行动心电遥测（MCT）技术的普及，正在为需要长期观察的高风险患者建立新的治疗标准。与传统的心电图监测不同，这种方法能够自动将异常心律资料传输到中央监测中心，从而最大限度地减少诊断和治疗的延迟。这种向互联互通和即时临床可视性的转变，正在显着提升领先医疗技术公司的收入，这些公司正不断拓展其诊断产品组合。根据波士顿科学公司于2025年2月发布的2024财年年度报告，该公司实现了167亿美元的年度净销售额，年增17.6%。这主要得益于全球需求的成长以及心臟病学领域的创新进步。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：血管心电图（ECG）市场的全球展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 按类型（携带式、补丁式、其他）
    • 透过应用（医院、动态心电图服务提供者、家庭护理机构等）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美门诊心电图（ECG）市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲门诊心电图（ECG）市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区门诊心电图（ECG）市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲门诊心电图（ECG）市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲门诊心电图（ECG）市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球动态心电图（ECG）市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • GE HealthCare Technologies Inc.
  • Hill-Rom Holdings, Inc.
  • Koninklijke Philips NV
  • Cardinal Health, Inc.
  • Cardiac Insight, Inc.
  • Bionet America, Inc.
  • Bardy Diagnostics, Inc.
  • EDAN Instruments, Inc.
  • Powerful Medical Inc.
  • HeartBeam, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 27576

The Global Ambulatory Electrocardiography ECG Market is projected to expand from USD 565.45 Million in 2025 to USD 867.32 Million by 2031, reflecting a compound annual growth rate of 7.39%. This sector involves the continuous tracking of cardiac electrical activity using portable instruments, such as Holter monitors or mobile telemetry systems, allowing patients to continue their everyday activities. The primary forces propelling this market include the rising global rates of cardiovascular disorders and atrial fibrillation, coupled with an aging population necessitating frequent cardiac surveillance. Furthermore, the strategic transition of healthcare frameworks toward remote patient monitoring to decrease hospital admissions bolsters the growing demand for these diagnostic instruments.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 565.45 Million
Market Size 2031USD 867.32 Million
CAGR 2026-20317.39%
Fastest Growing SegmentPortable
Largest MarketNorth America

However, market growth confronts significant hurdles related to intricate reimbursement protocols and data management difficulties, which hinder adoption in smaller healthcare institutions. Data from the European Society of Cardiology in 2024 indicates that cardiovascular disease is responsible for over 3 million annual deaths across its member nations. While this statistic underscores the urgent need for accessible diagnostic tools, financial limitations and regulatory complexities persist as barriers preventing widespread market saturation.

Market Driver

The increasing incidence of cardiovascular diseases and arrhythmias serves as the primary engine driving the Global Ambulatory Electrocardiography ECG Market. With the global impact of heart conditions growing heavier, healthcare systems are placing greater emphasis on continuous, non-invasive monitoring options to enable the early identification and treatment of atrial fibrillation and other conduction issues. This critical clinical need is supported by the elevated mortality rates linked to these ailments. According to the World Health Organization's 'Cardiovascular diseases (CVDs)' fact sheet from July 2025, cardiovascular diseases resulted in an estimated 19.8 million deaths worldwide in 2022, accounting for roughly 32% of global fatalities. Consequently, requests for ambulatory tools like Holter monitors and mobile telemetry systems have escalated as providers aim to improve patient outcomes via timely diagnostics outside standard hospital environments.

The second pivotal factor stimulating market growth involves technological breakthroughs in wearable devices and the incorporation of artificial intelligence. These innovations are swiftly moving the industry away from bulky wired recorders toward unobtrusive, patch-based sensors featuring AI algorithms designed for real-time arrhythmia detection and noise suppression. For example, Cardiovascular Business reported in July 2025 that the U.S. FDA cleared Cardiosense's CardioTag, a new wearable sensor capable of simultaneously recording electrocardiogram (ECG) and other physiological metrics to assess cardiac function. Such technological advancements are resulting in substantial commercial success and uptake. As noted in iRhythm Technologies' 'Fourth Quarter and Full Year 2024 Financial Results' from February 2025, the company achieved a 20.1% rise in annual revenue to $591.8 million, largely attributed to higher volumes of its Zio ambulatory monitoring services.

Market Challenge

Complicated reimbursement frameworks and data management difficulties function as major impediments to the expansion of the ambulatory electrocardiography market. Healthcare providers, especially smaller independent practices, frequently encounter difficulties with the administrative tasks necessary to obtain payment for long-term monitoring services. The complexity of coding structures and inconsistent coverage standards introduce revenue uncertainty, causing facilities to hesitate before investing in advanced mobile telemetry systems. Additionally, the massive amount of data produced by continuous monitoring necessitates significant storage and processing power, placing extra financial pressure on institutions that lack sophisticated information technology infrastructure.

These operational obstacles restrict market reach by effectively limiting services to major hospital networks. When clinics are unable to efficiently handle diagnostic data or ensure reimbursement, their likelihood of prescribing ambulatory monitoring decreases, which in turn stifles market volume. This bottleneck is particularly critical given the vast number of patients needing attention. According to the American Heart Association, cardiovascular disease impacted roughly 48.6 percent of the adult population in the United States in 2024. This figure highlights the enormity of the data management issue, as the widespread prevalence of cardiac conditions demands a scalable infrastructure that many facilities currently cannot support due to regulatory and economic constraints.

Market Trends

The merging of consumer wearables with clinical-grade ECG technology is transforming patient care pathways by making medical-grade arrhythmia detection possible through widely available devices. Manufacturers are frequently securing regulatory clearances for multi-sensor instruments that enable patients to record single-lead ECGs at home, thereby lessening the reliance on facility-based diagnostics. This development supports earlier treatment for issues such as atrial fibrillation by bringing clinical accuracy into everyday life, effectively closing the divide between lifestyle tracking and professional medical oversight. As reported by Femtech Insider in November 2025, within the article 'Withings Receives FDA Clearance for BeamO,' Withings obtained FDA approval for its BeamO device, a multiscope integrating an electrocardiogram with other sensors to conduct thorough health assessments in less than one minute.

Simultaneously, the widespread adoption of Mobile Cardiac Telemetry (MCT) for real-time monitoring is establishing a new standard of care for high-risk patients needing prolonged observation. This method differs from conventional Holter monitors by automatically sending abnormal rhythm data to centralized monitoring hubs, which minimizes the delay in diagnosis and treatment. This transition toward connectivity and instant clinical visibility is fueling substantial revenue increases for leading medical technology companies expanding their diagnostic portfolios. According to Boston Scientific's '2024 Annual Report' released in February 2025, the company achieved full-year net sales of $16.7 billion, a 17.6 percent rise, largely propelled by robust global demand and innovative progress within its cardiology divisions.

Key Market Players

  • GE HealthCare Technologies Inc.
  • Hill-Rom Holdings, Inc.
  • Koninklijke Philips N.V.
  • Cardinal Health, Inc.
  • Cardiac Insight, Inc.
  • Bionet America, Inc.
  • Bardy Diagnostics, Inc.
  • EDAN Instruments, Inc.
  • Powerful Medical Inc.
  • HeartBeam, Inc.

Report Scope

In this report, the Global Ambulatory Electrocardiography ECG Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ambulatory Electrocardiography ECG Market, By Type

  • Portable
  • Patch
  • Others

Ambulatory Electrocardiography ECG Market, By Application

  • Hospital
  • Holter Service Provider
  • Home
  • Others

Ambulatory Electrocardiography ECG Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ambulatory Electrocardiography ECG Market.

Available Customizations:

Global Ambulatory Electrocardiography ECG Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ambulatory Electrocardiography ECG Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Portable, Patch, Others)
    • 5.2.2. By Application (Hospital, Holter Service Provider, Home, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Ambulatory Electrocardiography ECG Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Ambulatory Electrocardiography ECG Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Ambulatory Electrocardiography ECG Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Ambulatory Electrocardiography ECG Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Ambulatory Electrocardiography ECG Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Ambulatory Electrocardiography ECG Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Ambulatory Electrocardiography ECG Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Ambulatory Electrocardiography ECG Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Ambulatory Electrocardiography ECG Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Ambulatory Electrocardiography ECG Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Ambulatory Electrocardiography ECG Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Ambulatory Electrocardiography ECG Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Ambulatory Electrocardiography ECG Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Ambulatory Electrocardiography ECG Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Ambulatory Electrocardiography ECG Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Ambulatory Electrocardiography ECG Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Ambulatory Electrocardiography ECG Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Ambulatory Electrocardiography ECG Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Ambulatory Electrocardiography ECG Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Ambulatory Electrocardiography ECG Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Ambulatory Electrocardiography ECG Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Ambulatory Electrocardiography ECG Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Ambulatory Electrocardiography ECG Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Ambulatory Electrocardiography ECG Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Ambulatory Electrocardiography ECG Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. GE HealthCare Technologies Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Hill-Rom Holdings, Inc.
  • 15.3. Koninklijke Philips N.V.
  • 15.4. Cardinal Health, Inc.
  • 15.5. Cardiac Insight, Inc.
  • 15.6. Bionet America, Inc.
  • 15.7. Bardy Diagnostics, Inc.
  • 15.8. EDAN Instruments, Inc.
  • 15.9. Powerful Medical Inc.
  • 15.10. HeartBeam, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer